The 20th Anniversary of Pharmaceuticals-Design of Potential Drugs by Modification of Natural Products

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".

Deadline for manuscript submissions: closed (15 August 2024) | Viewed by 2666

Special Issue Editor


E-Mail Website
Guest Editor
Chair of Chemistry, Department of Agriculture and Forestry, University of Warmia and Mazury, Olsztyn, Poland
Interests: medicinal chemistry; organic synthesis; biotransformations; enzyme inhibitors; organophosphonates; peptide mimetics; natural products in food
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Natural products are considered a rich source of therapeutic agents. They are also strategic in drug discovery programs, enabling the development of new and more effective lead compounds and contributing to addressing significant economic and societal challenges. Compared to synthetic molecules, natural products have the unusual features of structural diversity and complexity including the presence of many stereogenic centers and a lower number of nitrogen or halogen atoms. Substances deriving from natural sources usually are good lead compounds but are unlikely to meet the demands for druggability, suffering from various deficiencies or shortcomings. Therefore, it is beneficial or even necessary to modify and optimize these structural phenotypes.

The use of natural products as scaffolds for modification is a good approach to drug discovery and development. The structural modification of natural products is intended to increase potency and selectivity, improve physico-chemical, biochemical and pharmacokinetic properties, eliminate or reduce side effects of novel drugs, and attain intellectual properties.

Despite the many limitations associated with natural products, the various means of modification of their structure may lead to the discovery of a novel drugs. They include not only classically applied total synthesis, semisynthetic modifications, SAR-based modifications, or even a single atom alteration, but also many more approaches, which are presented below. Thus, this Special Issue invites all researchers and clinicians to publish works concerning the following and related fields:

1./ Strategies of simplification of natural drug structure.

2./ Multi-dimensional optimization of natural drugs.

3./ Reduction in the number of chiral centers.

4./ Manipulations increasing natural drug activity and selectivity.

5./ Improvement of natural drug pharmacological properties.

6./ Metabolomics in drug design.

7./ Late-stage modification of complex structures.

8./ Utilization of biosynthetic engineering.

9./ Genetic engineering in drug development.

10./ Combinatorial chemistry techniques.

11./ Fragment-binding methodology.

Prof. Dr. Paweł Kafarski
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural drugs as templates
  • drug structure optimization
  • natural product structure simplification
  • metabolomics
  • system biology in drug design 
  • biosynthetic engineering
  • large-stage modifications

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 4612 KiB  
Review
Engineering of Nisin as a Means for Improvement of Its Pharmacological Properties: A Review
by Mateusz Musiejuk and Paweł Kafarski
Pharmaceuticals 2023, 16(8), 1058; https://doi.org/10.3390/ph16081058 - 26 Jul 2023
Cited by 7 | Viewed by 2149
Abstract
Lantibiotics are believed to have a conceivable potential to be used as therapeutics, especially against clinically resistant bacterial strains. However, their low solubility and poor stability under physiological conditions limit their availability for clinical studies and further pharmaceutical commercialization. Nisin is a readily [...] Read more.
Lantibiotics are believed to have a conceivable potential to be used as therapeutics, especially against clinically resistant bacterial strains. However, their low solubility and poor stability under physiological conditions limit their availability for clinical studies and further pharmaceutical commercialization. Nisin is a readily available and cheap lanthipeptide and thus serves as a good model in the search for the tools to engineer lantibiotics with improved pharmacological properties. This review aims to address technologies that can be applied to alter and enhance the antimicrobial activity, antibacterial spectrum and physicochemical properties (solubility, solution stability and protease resistance) of nisin. There are basically two general means to obtain nisin analogs—protein engineering and chemical functionalization of this antibiotic. Although bioengineering techniques have been well developed and enable the creation of nisin mutants of variable structures and properties, they are lacking spectacular effects so far. Chemical modifications of nisin based on utilization of the reactivity of its free amino and carboxylic moieties, as well as reactivity of the double bonds of its dehydroamino acids, are in their infancy. Full article
Show Figures

Figure 1

Back to TopTop